Introduction
Breast cancer accounts for the highest incidence of cancer and cancer-related deaths in women in both developed and developing countries [1] . Many studies show a connection between diet and breast cancer, with cancer incidence inversely correlated with consumption of fruit and vegetables [2] [3] [4] [5] [6] [7] . Consumption of cabbage, in particular, may play an important role in decreasing the cancer risk [8, 9] . Indole-3-carbinol (I3C), a dietary compound found in cruciferous vegetables, such as cabbage, has shown chemopreventive potential in several tissues in animal models. I3C reduces incidence and multiplicity, and increases latency of mammary tumours in animal models [10] [11] [12] [13] [14] [15] . It exhibits chemopreventive effects against tumours induced by Some data shown in Figs. 1 and 2 were presented on the poster 596 at 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (Prague, Czech Republic, 07-10 November 2006) E. P. Moiseeva (&) Á R. Heukers Departments of Biochemistry and Cancer Studies, Cancer Biomarkers and Prevention Group, Biocentre, University of Leicester, Leicester LE1 7RH, UK e-mail: em9@le.ac.uk carcinogens [13, 15] and viruses [10] , and is also effective against spontaneous [11, 14] and xenograft tumours [12] .
I3C, an FDA-approved nutritional supplement, is effective in treatment of neoplasias and recurrent papillomatosis and is associated with very few side effects [16] [17] [18] . It may enhance efficacy of chemotherapeutic drugs and may be used in combination with them, e.g. a combination of I3C and tamoxifen reduced mammary tumourigenesis in a rat model in a cooperative manner [19] . Toxicity of an experimental anti-tumour drug ET-743, with promising activity in breast carcinoma and currently under phase-II clinical evaluation, was almost completely abolished by I3C in a rat model [20] . I3C can be converted into 3,3¢-diindolylmethane (DIM), a major in vivo acid-catalysed condensation product of I3C. The maximal serum concentrations of I3C and DIM were detected in mice at 30 min and 2 h, respectively, after I3C ingestion [21] , whereas only DIM was detected in humans 1-12 h after I3C ingestion, with the peak concentrations at 2 h [22] . Since maximal DIM concentrations, following I3C administration at similar doses (mg/kg), are comparable in mice and humans, the discrepancy in I3C detection is likely to be caused by sensitivity of methods and selection of time points. Nonetheless, several studies have revealed distinct responses to I3C and DIM in vivo [20, [23] [24] [25] [26] . Therefore, the in vivo activity of dietary I3C cannot be attributed completely to the production of DIM, although partial response due to DIM conversion is feasible.
The I3C exerts several effects that may contribute to cancer prevention. It induces phases-I and II enzymes [11, 14, 15, 19] , leading to increased catabolism and excretion of carcinogens and oestradiol. It also elicits anti-proliferative and pro-apoptotic responses in oestrogen receptor (ER)-alpha-negative breast cancer cells. Several molecular mechanisms have been suggested for I3C-induced cell death. Inhibition of Akt activity was proposed as a proapoptotic event [27, 28] . However, later studies showed that down-regulation of Akt does not account for I3C-induced apoptosis in several breast cancer lines [29] . Epidermal growth factor receptor (EGFR) down-regulation and modulation of Src were found critical in I3C-induced apoptosis in several subtypes of breast cancer cells [30, 31] . Inhibition of NF-jB pathway by I3C has been found in several types of cancer cells [28, 32, 33] .
The NF-jB pathway is most commonly involved in suppression of apoptosis by transactivation of expression of anti-apoptotic genes, e.g. Bcl-xL, although it also can promote cell death in response to certain signals in some cell types [34] . NF-jB regulates expression of multiple genes, including all NF-jB inhibitors, i.e. IjBa, IjBbIjBep105/IjBc and p100/IjBd [35] . It is implicated in cancer development, progression to malignancy and therapy resistance [36] . NF-jB is constitutively up-regulated in breast tumours and is activated in most breast cancer cell lines, regardless of the ER status. Amplification of the RelA/p65 gene and aberrant nuclear expression of multiple subunits, including p50, p52, RelA, RelB and c-Rel, has been shown in human primary breast cancers [36] [37] [38] [39] . The causes of constitutive activation of NF-jB are numerous. Elevated levels of IKK activity in breast tumours and cell lines, as well as decreased levels of IjB are well documented [36] . CK2, which also phosphorylates IjB, is implicated in NF-jB up-regulation in the mammary cell lines and tumours [40] . Some breast cancer cells secrete cytokines, which generate autocrine NF-jB activation, e.g. MDA-MB-231 cells produce high levels of IL-1 and TNFa and HBL100 cells also secret IL-1 [41, 42] . Increased EGFR signalling is involved in regulation of NF-jB and increased p50/p105 levels in breast cancer cells [43, 44] . Up-regulated PI3K/Akt activity, due to loss of PTEN or up-regulated growth factor signalling, also causes activation of NF-jB in breast cancer cells [45] .
Constitutive NF-jB signalling augments expression of metastatic biomarkers, e.g. IL-6, ICAM1 and uPA [41, 46, 47] , and anti-apoptotic Bcl-xL [34] ; the latter is also involved in increased metastatic spreading and resistance to TNFa in breast cancer [48, 49] . The causal role of NF-jB in breast cancer development and progression to malignancy, as well as in chemo-and radio-therapy resistance, makes this pathway an attractive therapeutic target. The role of NF-jB signalling in I3C-induced inhibition of cancer cell survival has not been elucidated and was the aim of this study.
Materials and methods

Cells
Human breast cell lines MDA-MB-468, MDA-MB-231 and HBL100 originated from the American Type Culture Collection, Rockville, MD, USA. The cell lines were cultured in DMEM with 10% foetal bovine serum (FBS), as described previously [30] . They all belong to the basal-like breast cancer subtype [50] .
Immunoblotting and immune precipitation
Preparation of whole cell lysates, immune precipitation, SDS-PAGE and immunoblotting were performed as described previously [31] . The polyclonal antibodies against IKKb, NF-jB p65 (C-terminus), NF-jB p50 (C-terminus), monoclonal antibodies against phospho-IjBa and lamin A/C were purchased from Santa Cruz, California, CA, USA. The other polyclonal antibodies against NF-jB p65 (N-terminus), p50 (N-terminus), p52 (N-terminus), RelB (C-terminus) and cRel (internal) were a kind gift from Dr Nancy Rice [51] .
Electromobility shift assay (EMSA)
Standard techniques with addition of phosphatase inhibitors were used to prepare cytoplasmic and nuclear extracts [28, 32] . Cells were extracted with a hypotonic buffer [10 mM Hepes, pH 7.8, 10 mM KCl, 2 mM MgCl 2 , 1 mM DTT, 0.1 mM DTT, 0.4% NP40, inhibitors for proteases and phosphotyrosine and phosphoserine/phosphothreonine phosphatases (all cocktails from Sigma, Poole, UK)] to obtain cytoplasmic extracts. The remaining pellet was extracted with a hypertonic buffer [50 mM Hepes, pH 7.8, 50 mM KCl, 300 mM NaCl, 0.1 mM DTT, 10% glycerol, inhibitor cocktails as above] to obtain nuclear extracts. A [ 32 P]-5¢ labelled NF-jB consensus oligonucleotide duplex 5¢-AGTTGAGGGGACTTTCCCAGGC (Promega, Southampton, UK) or STAT5 consensus oligonucleotide duplex 5¢-AGATTTCTAGGAATTCAATCC (Santa Cruz), separated from non-incorporated [ 32 P]ATP, were used in EMSA. Normalised extracts containing equal protein levels were incubated with 3.5 pmol of labelled oligonucleotides in the gel shift binding buffer (Promega) for 20 min at room temperature, followed by separation in non-denaturing 7% PAGE. For supershifts, 2.5 ll of antibodies were incubated with nuclear extracts for 20 min at room temperature prior to addition of the 5¢-labelled oligonucleotide and an excess of the unlabelled oligonucleotide. Protein-DNA complexes were quantified by autoradiography of dry gels using a phospho-imager (Storm 820, Molecular Dynamics, Amersham Pharmacia Biotech, UK).
Transfection
The NF-jB transcriptional activity was evaluated using transient transfection with a gene-reporter pNF-jBLuc plasmid (Stratagene, La Jolla, CA, USA), containing the firefly luciferase reporter gene regulated by a promoter with multiple NF-jB sites. A plasmid pRL-SV40 (Promega, Southampton, UK), containing a renilla luciferase reporter gene, was used as an internal control of transfection efficiency. Conditions and reagents were optimised for maximal transfection efficiency in MDA-MB-468 cells. The following protocol was used in all experiments: cells, seeded in Packard Viewplates-96 (2,500 cell/well) in 10% FBS in DMEM the previous night, were transfected with 50 ng/well pNF-jB-luc DNA and 8 ng/well pRL-SV40 DNA using 0.3 ll/well of GeneJuice transfection reagent (Novagen, Madison, WI, USA) in 100 ll of DMEM for 2 h, followed by the same volume of 20% FBS in DMEM, as previously [31] .
After 36-48 h, cells were treated with I3C, TNFa or specific inhibitors for the indicated number of hours.
Luciferase activities were measured using a dual luciferase assay kit LucLite (Perkin-Elmer, Boston, MA, USA, discontinued) or Dual-Glo luciferase assay system (Promega, Southampton, UK) according to the manufacturers' instructions in a FluoStar luminometer (BMG, London, UK). The data are presented as a percentage of the ratio of activities of firefly luciferase to renilla luciferase.
Quantification of gene expression
Total RNA from cells was isolated using a Qiagen kit. cDNA was synthesised using a Promega reverse transcription kit. The cDNA amounts transcribed from 50 ng of RNA were used in real-time PCR (ABI 7300) to quantify the levels of mRNA for Bcl-xL, ICAM1, IjBa, uPA and IL-6 and 18S RNA using Taqman probes (gene expression products from Applied Biosystems, Warrington, UK), as previously described [31] . The levels of gene expression were calculated by DCT method, using 18S RNA as a reference.
Cell viability and apoptosis-related studies Cells were seeded overnight in 10% FBS in DMEM, followed by treatments in the same medium. The number of viable adherent cells was estimated using the ATPlite kit (Perkin-Elmer) and caspase 3/7 activity, as a measure of apoptosis, was determined using a Caspase-Glo 3/7 kit (Promega) as described previously [30] . The percentage of live, apoptotic or necrotic cells in the whole population was measured using annexin V binding to externalised phosphatidylserine with the Annexin V-FITC kit (Bender Medsystems, Vienna, Austria) as described previously [30] .
Data analysis
Differences among the groups were analysed using one-way ANOVA in Statistical Package for the Social Sciences, followed by Scheffe's test to determine whether the treatment groups were different, or Dunnett's test to determine whether the treatment groups were different from a control group. P < 0.05 was selected as the level of statistical significance.
Results
NF-jB constitutive activation and signalling in breast cancer cells
Immunoblotting of nuclear and cytoplasmic extracts showed that all NF-jB subunits are present in both frac- tions in various amounts (Fig. 1A) . The pattern of expression was similar in HBL100 and MDA-MB-231 cells: RelA (p65), RelB, cRel and p52 were present at similar levels in both extracts. Surprisingly, p105 and p100 were also present in nuclear extracts. The expression pattern in MDA-MB-468 cells was different. NF-jB p105 was absent, a doublet of p52 was present and lower levels of p65 and cRel were present in the nuclear extract, with cRel expressed at a much higher level in cytoplasmic extract. NF-jB DNA binding in cells was represented by two specific bands, UB and LB, with slightly stronger LB in HBL100 (Fig. 1B, C) . Constitutive NF-jB DNA binding in these cell lines is in agreement with published data [28, 44, 47] . Since the DNA binding in MDA-MB-231 cells was similar to MDA-MB-468 cells (Fig. 1B) , only nuclear extracts of HBL100 and MDA-MB-468 cells were analysed. Antibodies against C-termini of p65 and p50, marked SC, prevented NF-jB DNA binding in the lower band in both cell lines. Other antibodies significantly reduced DNA binding in the upper band. Antibodies against p65-N-terminus and cRel also reduced the LB in HBL100 cells. Hence, the LB is likely to be mostly a p65/p50 heterodimer, whereas the upper band is likely to represent various NF-jB heavier complexes, possibly with other transcription factors. The lower band was more intense in HBL100 and MDA-MB-231 cells compared to MDA-MB-468, which had less nuclear p65 (compare Fig. 1A-C) .
The NF-jB transcriptional activity, measured as NF-jBregulated reporter gene expression, was significantly lower in HBL100 cells compared to the other cells (Fig. 1D) . Activity was in the following order MDA-MB-231 >> MDA-MB-468 >> HBL100. This is in agreement with the expression of an NF-jB-regulated set of antiapoptotic genes in these cell lines [52] .
NF-jB-regulated expression of mRNA for IL-6, ICAM-1, uPA, Bcl-xL and IjBa, regulated by different Rel dimers in various cell types [53, 54] , were measured in the cells (Fig. 1E) . No differences in ICAM-1 mRNA levels were found in three cell lines. The mRNA expression levels for uPA, IL-6, Bcl-xL and IjBa were in the following order MDA-MB-231 > HBL100 ‡ MDA-MB-468, although not all differences were statistically significant. Expression of uPA mRNA correlated with reported levels [47] and invasiveness of the cells [55] .
Modulation of constitutive NF-jB signalling did not correlate with cell survival Regulation of NF-jB transcriptional activity in breast cancer cells by PI3K, Src, EGFR and IKKb was investigated using specific inhibitors. Aspirin was used as a specific IKKb inhibitor [56] . Inhibition of PI3K with 10 lM LY294002, EGFR with 1 lM PD 153035 or IKKb with 100 lM aspirin modulated NF-jB-regulated reporter gene expression in a cell-specific manner ( Fig. 2A) with LY294002 affecting all cell lines. A treatment time of 24 h was chosen to examine a steady-state of NF-jB constitutive activation. Reduced reporter gene expression by LY294002 coincided with increased mRNA expression of NF-jB inhibitor IjBa and Bcl-xL in HBL100 cells, but no changes in mRNA levels were found in MDA-MB-231 cells (Fig. 2B) . Similarly, reduced NF-jB signalling and NF-jB-regulated reporter gene expression by LY204002 in MDA-MB-231 cells were found previously [57, 58] . Increased reporter gene expression by LY294002 coincided with reduced IL-6 levels in MDA-MB-468 cells (Fig. 2B) . Hence, regulation of NF-jB target genes was also cell-specific.
LY294002 reduced cell number in HBL100 cells, reduced caspase 3/7 activity in HBL100 and MDA-MB-231 cells, but no changes in the percentage of live/apoptotic/ necrotic cells were found (Fig. 2C-E) . Hence, PI3K inhibition in HBL100 cells resulted in a decreased cell number due to decreased proliferation, but did not increase cell death, possibly, due to increased transcription of Bcl-xL. Aspirin, EGFR and Src inhibitors induced caspase 3/7 activity in cell line-specific manner (Fig. 2D ), although this increase was low (<150%) and did not affect cell number. Altogether, all inhibitors had a cell-specific effect on NFjB-regulated reporter gene activity, while LY294002 influenced it in all cell lines; however, alterations in NF-jB-regulated reporter gene levels did not correlate with cell death.
Effect of I3C on NF-jB and apoptosis
We showed previously that I3C induced a chain of events initiated by increased tyrosine phosphorylation at 5-h treatment, involving Src activation in MDA-MB-468 and HBL100 cells, and proceeded at a different speed to induce apoptosis in MDA-MB-468 (at 16 h), and MDA-MB-231 (at 24 h). No apoptosis was detected in HBL100 despite significantly increased tyrosine phosphorylation [30, 31] .
Here we investigated NF-jB signalling in I3C-treated MDA-MB-468 and HBL100 cells over a period of 6-24 h (Fig. 3A, B) . NF-jB-regulated reporter gene expression increased at 12-h treatment to 134 ± 7 and 130 ± 5% by 100 and 250 lM I3C, respectively, in MDA-MB-468 cells and gradually decreased from 18 h (not shown) to 24 h of treatment to 64 ± 7% in HBL100 cells. Thus, NF-jB signalling in these cell lines responded to I3C treatment in a cell-specific manner, as in experiments shown in Fig. 2 . Sarkar and co-authors [12] have shown that I3C decreased NF-jB DNA binding and decreased NF-jB regulated target genes in MDA-MB-231 cells in cell culture and an animal model. The changes in the reporter gene expression involve modulation of NF-jB signalling and translocation, resulting in reporter gene transcription followed by translation, which would take about 4-6 h. Therefore, changes in NF-jB signalling would have to take place at about 6 h to account for the increase in the reporter gene activity at 12 h in MDA-MB-468 cells. Hence, we conducted experiments to verify that I3C did indeed induce NF-jB signalling at 6 h. Cells were treated for either 1 or 6 h with I3C, followed by incubation in fresh medium for another 5 h to allow the reporter gene transcription and translation to take place. I3C induced NF-jB signalling following a 6 h treatment in MDA-MB-468 cells (137 ± 5% vs. 100 ± 4%), but not HBL100 (Fig. 3C) . When the same I3C treatments were combined with a classic NF-jB inducer TNFa, a significant increase in NF-jB-regulated reporter gene expression (311 ± 16% vs. 196 ± 6%) was observed in MDA-MB-468 cells in a combined treatment with I3C (6 h) + TNFa (the last 30 min), compared with TNFa (30 min) treatment. In contrast, a significant increase in NF-jB-regulated reporter gene expression was observed in HBL100 cells in response to TNFa only. These experiments confirmed that I3C induced NF-jB signalling at 6 h specifically in MDA-MD-468 cells.
Since I3C induces transient activation of Src Þ EGFR signalling in MDA-MB-468 cells, responsible for I3C-induced apoptosis [31] , we examined whether transient Src activation may be involved in I3C-induced NF-jB signalling. Increased phosphorylation of IjBa was observed at 4.5-5 h coinciding with Src activation (Fig. 4A) . IKKb, shown to be activated and phosphorylated on Tyr188 and Tyr199 by Src [59] , was co-immunoprecipitated with the Src-EGFR complex after 5-h treatment with I3C (Fig. 4B) . NF-jB DNA binding in the lower band was induced at 6.5 h in MDA-MB-468, but not other cells (Fig. 4C, D) . No such changes were found in STAT5 DNA binding in MDA-MB-468 cells, but some increase was observed at 6.5 h in MDA-MB-231 and HBL100 cells. PP2, a specific Src inhibitor, reduced NF-jB DNA binding in LB, induced by I3C (Fig. 4D) . Similarly, Src-mediated activation of NF-jB and PP2-caused reduction in induced NF-jB DNA binding was shown previously [59] [60] [61] . Collectively these data indicate that I3C-induced NF-jB signalling is likely to be related to Src activation in MDA-MB-468 cells, but not HBL100.
Next we investigated I3C-induced apoptosis. I3C induced caspase 3/7 activation in MDA-MB-468 and MDA-MB-231 cells, but not in HBL100 (Fig. 5) , as reported previously [30] . Therefore, there was no correlation between I3C-reduced NF-jB signalling and cell death. TNFa alone induced apoptosis only in HBL100. However, a combination treatment with I3C + TNFa increased apoptosis in all cell lines. This increase was fairly low in MDA-MB-468 cells (22.5 ± 0.7-fold against 18.7 ± 1.0 by 250 lM 3C), but was about twofold in MDA-MB-231 (12.2 ± 0.5-fold against 5.9 ± 0.1 by I3C) and HBL100 (3.3 ± 0.1-fold against 1.8 ± 0.1 by TNFa) cells. Thus, a combination treatment with I3C + TNFa was efficacious against all cell lines.
Discussion
NF-jB constitutive activation in breast cancer cells was cell-specific
Analysis of Rel proteins showed similarities between HBL100 and MDA-MB-231 cells and a distinct expression pattern in MDA-MB-468 cells. It is interesting to note that Rel subunits were present together with p105 and/or p100 in nuclear extracts. Despite the general assumption that p100 and p105 should be processed into p50 and p52, respectively, before nuclear translocation, nuclear presence of p105 and p100 was demonstrated previously [62, 63] . The data presented by Saccani et al. [63] indicate that p105/p100 processing may be uncoupled from nuclear translocation. Moreover, analysis of p105 heterodimers, e.g. p65/p105 or p50/p105, revealed an exposed nuclear localisation signal, which requires an additional factor to be retained in cytoplasm [64] . The physiological role of p100 or p105 in the nucleus has not been investigated. Altogether, constitutive activation of NF-jB is likely to be related to nuclear presence of multiple Rel proteins with a cell-specific expression pattern. NF-jB DNA binding differed between cell lines: the lower band, which is likely to be a p65/p50 heterodimer, had lower mobility in HBL100 cells, which may be related to modification of NF-jB subunits [53] . Similarly, strong DNA binding with differential activation of NF-jB-regulated genes was found in these breast cancer cells previously [47, 52] . It is generally recognised that total NF-jB DNA binding does not correlate with NF-jB activity: DNA binding by some Rel dimers is not sufficient for promoter activation; e.g. p50/p50 dimer can be a transcriptional repressor [35] .
The order of mRNA levels for uPA, IL-6, Bcl-xL and IjBa in the cell lines (MDA-MB-231 > HBL100 ‡ MDA-MB-468) did not correlate with the order of the NF-jBregulated reporter gene levels (MDA-MB-231 >> MDA-MB-468 >> HBL100). Nonetheless, the mRNA levels for these biomarkers correlate with the NF-jB-regulated reporter gene levels in the cell lines with the similar expression pattern of the Rel proteins, i.e. in MDA-MB-231 and HBL-100 cells. The levels of IL-6 and uPA mRNA correspond to the increased levels of autocrine IL-1 with specific NF-jB induction in MDA-MB-231 and HBL100 cells or to the absence of IL-1 in MDA-MB-468 cells [41] . Many other factors may be involved in regulation of these genes, e.g. epithelial-mesenchymal transition with modulated DNA methylation and uPA up-regulation is reported for MDA-MB-231 and HBL100 cells [65] . Importantly, the aggressive metastatic cancer MDA-MB-231 cells showed the highest levels of NF-jB-regulated expression of the reporter gene and metastatic biomarkers Bcl-xL, IL-6 and uPA, consistent with their metastatic potential.
Modulation of constitutive NF-jB activity did not correlate with cell survival The significance of IKK or PI3K/Akt signalling in NF-jB is well documented, whereas involvement of Src and EGFR is less recognised. Src is linked to induced NF-jB signalling via physical association and phosphorylation of Tyr188 and Tyr199 of IKKb [59, 66] and also via phosphorylation of IjBa on Tyr42 in inducible NF-jB signalling [67, 68] . EGFR influences NF-jB via association with TNFR-interacting protein RIP [69] and SHP-2/Gab1 proteins, with SHP-2 being a dual regulator of NF-jB [70] . PI3K modulates NF-jB via multiple mechanisms. The regulatory subunit p85a associates with and sequesters phosphotyrosine phosphorylated IjBa from NF-jB heterodimers, whereas inhibition of the catalytic subunit p110 results in inhibition of Akt [71] . In turn, Akt induces IKK activity and enables p65 translocation via p65 phosphorylation [53] .
Treatment with LY294002, a specific PI3K inhibitor, which also inhibits CK2 [72] , modulated the reporter gene expression in all cell lines, whereas treatments with aspirin and the EGFR inhibitor had effect only in MDA-MB-231 cells. Effects of aspirin on NF-jB may be related directly to IKKb or indirectly to COX2 activity. Our data suggest that regulation of constitutive NF-jB activity, measured as NF-jB-regulated reporter gene activity, and expression of genes regulated by this pathway is breast cancer cell-specific. For example, LY294002 also modulated expression of NF-jB target genes in HBL100 (Bcl-xL and IjBa) and MDA-MB-468 (IL-6) cells, but not in MDA-MB-231.
Moreover, modulation of constitutive NF-jB did not affect survival nor caused cell death in any cell line, though reduced cell number due to inhibition of proliferation was observed in HBL100 cells. Our data are in agreement with other studies. Recent investigation with down-regulation of RelA, IKKa, IKKb and IKKc by siRNAs found no correlation between NF-jB and apoptosis in MDA-MB-231 cells [73] . In particular, a decrease in p65 protein had no effects on apoptosis or cell proliferation, thus questioning the importance of NF-jB alone in the maintenance of these cells. It is plausible, that fairly small decrease (35 ± 4%) in NF-jB-regulated reporter gene expression in MDA-MB-231 cells with extremely high-constitutive activity may be not sufficient to reduce viability or decrease gene expression of NF-jB-regulated genes.
Altogether, our data indicate that there are some similarities in the effect of LY294002 on the NF-jB-regulated reporter gene expression and caspase 3/7 activity in MDA-MB-231 and HBL100 cells in contrast to MDA-MB-468 cells. Likewise, the pattern of expression of the Rel proteins and the mRNA levels of IL-6 and uPA were much higher in the former cell lines. Both of them belong to the basal B subtype, in contrast to MDA-MB-468 cells with the basal A subtype [50] , therefore, investigation of contribution of the NF-jB pathway to the subtype characteristics will be of great interest and potential clinical importance.
Modulation of NF-jB signalling by I3C was not related to I3C-induced apoptosis An extensive study conducted by Aggarwal and co-authors [33] demonstrated that I3C suppressed constitutive NF-jB activation, TNFa-induced NF-jB DNA binding and NFjB-regulated reporter gene expression, without affecting cell viability, in myeloid and leukaemia cells. TNFa-induced NF-jB activation was prevented by I3C via inhibition of IKK, which resulted in reduced IjBa phosphorylation in that study. The response of HBL100 cells with regard to I3C-mediated down-regulation of constitutive NF-jB activation, as well as sensitivity to TNFa-induced cell death was similar to those of myeloid and leukaemia cells. However, TNFa-induced NF-jB activation was reduced by I3C in myeloid and leukaemia cells, but not in HBL100. Possibly I3C treatments longer than used in this study (6 h ) are required to produce this effect in HBL100 cells. Recently Sarkar and co-authors examined the role of NF-jB in I3C-induced inhibition of MDA-MB-231 cells in cell culture and an animal model [12] . They found that I3C decreased levels of Bcl2 and increased Bax levels, decreased NF-jB DNA binding and expression of NF-jB regulated targets (MMP9 and CXR4) after 72 h treatment in culture. The reduced Bcl2/Bax ratio is likely to reflect ongoing apoptosis. These cells do undergo apoptosis in response to I3C (Fig. 5 [30] ). The authors also show decreased NF-jB DNA binding in two tumours and similar protein changes in one tumour from I3C-fed mice. Thus, I3C decreased NF-jB and expression of metastatic NF-jBregulated biomarkers in MDA-MB-231 cells both in vitro and in vivo [12] .
Other data on modulation of NF-jB by I3C in cancer cells are fragmented and lacking quantification. Decreased NF-jB DNA binding, coinciding with significant I3C-induced apoptosis, was found in prostate PC3 cells by Sarkar and co-authors [32] . Since NF-jB p50 and p65 are substrates for caspases [74] , reduction in NF-jB DNA binding during apoptosis is likely to be a result of increased caspase activity, but not an initiating event in I3C-induced cell death. Similarly, I3C decreased NF-jB DNA binding at 5-h treatment with 250-1,000 lM I3C in MDA-MB-468, but not HBL100 cells [28] . Extremely high I3C concentrations up to 500-1,000 lM, used in that study, induce apoptosis at 5 h [29] and are likely to produce artificial results. Another study by Rahman et al. [75] , reporting that NF-jB DNA binding and reporter gene expression in malignant breast MCF10CA1a cells were regulated by overexpression of Akt and influenced by I3C via Akt down-regulation, did not provide functional evidence of reduced NF-jB in apoptosis [75] .
Our data suggest that the effect of I3C or specific inhibitors on NF-jB signalling varies in breast cancer cell lines. NF-jB-regulated reporter gene expression was down-regulated in HBL100 cells, but was transiently increased in MDA-MB-468 cells. NF-jB DNA binding (LB) was also increased at 6.5 h, the time equivalent to the reporter gene rise in these cells, and was reduced by Src inhibition. I3C-induced increase in DNA binding was also preceded by physical association of IKKb with the activated Src-EGFR complex and increased phosphorylation of IjBa. Interestingly, an increased IKK activity at 5-h treatment with 250-750 lM I3C was shown previously [28] . On the contrary, no changes in NF-jB DNA binding were found in other cells, some increase was observed in STAT5 DNA binding in this study. This may be related to differential Src signalling in those cells; e.g. I3C-induced Src activation involved CAS signalling in HBL100 cells [31] . Transcriptional activation of STAT5b is shown to be related to Src activity in MDA-MB-231 cells [76] . Hence, these data support the important roles of Src and EGFR in I3C-induced signalling. Although the mechanism of I3C-induced down-regulation of NF-jB in HBL100 cells is not clear; it is not related to Akt, since no changes in total or pS473 Akt were detected in HBL100 cells treated with I3C for 18-30 h [30] . Neither has the cause of I3C-induced NF-jB down-regulation in MDA-MB-231 cells, myeloid or leukaemia cells been elucidated.
I3C-induced transient increase in the NF-jB signalling in MDA-MB-468 cells is unlikely to cause apoptosis, since prominent LY294002-induced up-regulation of this pathway caused only a slight increase in caspase 3/7 activity, but did not change either the cell number or phosphatidylserine externalisation (compare Figs. 2, 3, 5) . Likewise, I3C-induced decrease in the NF-jB signalling in HBL100 cells was not related to apoptosis, as a similar decrease, induced by LY294002, reduced the cell number without cell death in HBL100 cells (compare Figs. 2, 3, 5) . Hence, there was no correlation between I3C-induced modulation of NF-jB and I3C-induced apoptosis in breast cancer cells in our study. There are no data in this study to support a causal role of NF-jB in I3C-induced apoptosis. However, I3C potentiated TNFa-induced cell death in TNFa-sensitive myeloid and leukaemia cells [33] and HBL100 cells. Moreover, I3C-induced apoptosis was enhanced by TNFa in TNFa-resistant MDA-MB-468 and MDA-MB-231 cells. Therefore, combinations of I3C with other cytotoxic agents should be investigated with regard to cancer cell death.
Collectively, our data show that the regulation and consequences of constitutive nuclear NF-jB are cell-specific and the pathway is regulated in a complex way, which results in cell-specific modulation of expression of NF-jBregulated reporter gene and endogenous target genes in breast cancer cells. I3C caused cell-specific modulation of this pathway, which was not related to I3C-induced cell death. Our data warrant further investigation into chemopreventive efficacy of I3C in combined treatments.
